Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
暂无分享,去创建一个
J. Heyse | K. O'Brien | P. van Damme | S. Black | T. Vesikari | P. Offit | M. Santosham | D. Matson | J. Watt | H. Shinefield | Penny M Heaton | P. Dennehy | Zoe M Rodriguez | Michelle G. Goveia | M. Dallas | J. Boslego | M. Dinubile | H. Clark | S. Ylitalo | R. Itzler | C. Christie | L. Gothefors | B. Adeyi | G. Marshall | M. Coia | Matthew T. Onorato | D. Campens | A. Karvonen | Dirk Campens | Ben A. Adeyi | Zoe M. Rodriguez
[1] Robert T. Chen,et al. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone? , 2004, Pediatrics.
[2] R. Ward,et al. Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group. , 1997, The Journal of infectious diseases.
[3] S. Coffin,et al. Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice , 1997, Journal of virology.
[4] R. Glass,et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. , 2000, The Journal of infectious diseases.
[5] C. von Bonsdorff,et al. Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[6] R. Glass,et al. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. , 1999, Vaccine.
[7] R. Ward,et al. Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassay. , 1987, Diagnostic microbiology and infectious disease.
[8] T. Vesikari,et al. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. , 1998, The Pediatric infectious disease journal.
[9] B. Schwartz,et al. Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.
[10] Withdrawal of rotavirus vaccine recommendation. , 1999, MMWR. Morbidity and mortality weekly report.
[11] K. Dolan,et al. Epidemiology of rotavirus electropherotypes determined by a simplified diagnostic technique with RNA analysis , 1985, Journal of clinical microbiology.
[12] P. Offit,et al. Vaccines for rotavirus gastroenteritis universally needed for infants. , 2004, Pediatric annals.
[13] M. Estes,et al. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. , 1994, The Journal of infectious diseases.
[14] B. Turnbull,et al. Group Sequential Methods with Applications to Clinical Trials , 1999 .
[15] X. Pang,et al. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis , 1997, The Lancet.
[16] Y. Hoshino,et al. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine , 2005, Reviews in medical virology.
[17] G. Peter,et al. Intussusception, rotavirus, and oral vaccines: summary of a workshop. , 2002, Pediatrics.
[18] J. Ward,et al. Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. , 2002, The Pediatric infectious disease journal.
[19] R. Glass,et al. The future of rotavirus vaccines: a major setback leads to new opportunities , 2004, The Lancet.
[20] Robert T. Chen,et al. Population-based study of rotavirus vaccination and intussusception , 2001, The Pediatric infectious disease journal.
[21] R. Glass,et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. , 1996, The Journal of infectious diseases.
[22] A. Shaw,et al. Novel Rotavirus VP7 Typing Assay Using a One-Step Reverse Transcriptase PCR Protocol and Product Sequencing and Utility of the Assay for Epidemiological Studies and Strain Characterization, Including Serotype Subgroup Analysis , 2005, Journal of Clinical Microbiology.
[23] T. Byers,et al. The effects of infant feeding on rotavirus-induced gastroenteritis: a prospective study. , 1986, American journal of public health.
[24] S. M. Hewitt,et al. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1999, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[25] Mark A. Miller,et al. Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.
[26] R. Holman,et al. Trends in intussusception-associated hospitalizations and deaths among US infants. , 2000, Pediatrics.
[27] L. Moulton,et al. The protective effectiveness of natural rotavirus infection in an American Indian population. , 1998, The Journal of infectious diseases.
[28] B. Schwartz,et al. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions. , 1998, The Pediatric infectious disease journal.
[29] R. Glass,et al. Safety and Efficacy of High-dose Rhesus-Human Reassortant Rotavirus Vaccines-Report of the National Multicenter Trial , 1996, Pediatrics.
[30] R. Glass,et al. Rotavirus infection in infants as protection against subsequent infections. , 1996, The New England journal of medicine.
[31] R. Holman,et al. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. , 1998, The Pediatric infectious disease journal.
[32] P. Offit,et al. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. , 2005, The Journal of infectious diseases.
[33] M. Pichichero,et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. , 2004, The Journal of pediatrics.
[34] R. Yolken,et al. SEQUENTIAL ENTERIC ILLNESSES ASSOCIATED WITH DIFFERENT ROTAVIRUS SEROTYPES , 1978, The Lancet.